Sotera Health Co (SHC): Gross Profit

Annual figures by period end, from SEC filings.

$645.53M
Year ended 2025-12-31
$668.51M
Trailing 12 months to 2026-06-30
+5.0%
3-year compound annual growth
+7.8%
5-year compound annual growth
2019-12-31: $395.43M2020-12-31: $443.57M2021-12-31: $518.67M2022-12-31: $557.00M2023-12-31: $577.16M2024-12-31: $602.29M2025-12-31: $645.53M$645.53M
2019-12-31 Gross Profit (USD) 2025-12-31
Period endedGross ProfitChange YoYSource filing
2025-12-31$645.53M+7.2%2026-02-24, From 2025-01-01
2024-12-31$602.29M+4.4%2026-02-24, From 2024-01-01
2023-12-31$577.16M+3.6%2026-02-24, From 2023-01-01
2022-12-31$557.00M+7.4%2025-02-27, From 2022-01-01
2021-12-31$518.67M+16.9%2024-02-27, From 2021-01-01
2020-12-31$443.57M+12.2%2023-02-28, From 2020-01-01
2019-12-31$395.43Mn/a2022-03-01, From 2019-01-01

Gross Profit at similar companies

Companies with the same SEC industry code (Services-Misc Health & Allied Services, NEC), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedGross ProfitChange YoY
Sotera Health Co (SHC)2025-12-31$645.53M+7.2%
Progyny, Inc. (PGNY)2025-12-31$304.48M+20.2%
Viemed Healthcare, Inc. (VMD)2025-12-31$155.46M+16.7%
Cryo Cell International Inc (CCEL)2025-11-30$24.19M+0.6%
Mangoceuticals, Inc. (MGRX)2025-12-31$250.4K-34.1%
BioRestorative Therapies, Inc. (BRTX)2025-12-31$335.9K-9.9%

Compare SHC, PGNY, VMD, CCEL side by side · Screen every company in Services-Misc Health & Allied Services, NEC ↗